ALCAM and breast carcinoma: Another breast cancer-related study demonstrated that in patients with breast cancer (n = 157), the serum levels of soluble ALCAM were significantly higher than control individuals, and the levels correlated with shorter disease-free survival, although not with other clinical and pathological factors [134].